Serum KLRB1 (CD161) as a discriminative biomarker in community-acquired pneumonia
Serum KLRB1 may serve as a valuable biomarker to differentiate between viral and bacterial CAP, supporting early diagnosis and optimized treatment decisions.
Serum KLRB1 may serve as a valuable biomarker to differentiate between viral and bacterial CAP, supporting early diagnosis and optimized treatment decisions.
Although Türkiye implemented a national cervical cancer screening program in 2014, the Human Papillomavirus (HPV) vaccine has yet to be included in the national immunization sch...